Cite
Randomized double-blind evaluation of dronabinol for the prevention of chemotherapy-induced nausea
MLA
Jeffrey K. Giguere, et al. “Randomized Double-Blind Evaluation of Dronabinol for the Prevention of Chemotherapy-Induced Nausea.” Journal of Clinical Oncology, vol. 30, May 2012, p. 9061. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a055976fa2ac16a41d6a850c4272435d&authtype=sso&custid=ns315887.
APA
Jeffrey K. Giguere, Ulla Jo Ule, Joanna K. Metzner-Sadurski, Phuong Khanh Morrow, Michael J. Fisch, Steven M. Grunberg, Adedayo A. Onitilo, Steven J. Saccaro, & Mark F. Munsell. (2012). Randomized double-blind evaluation of dronabinol for the prevention of chemotherapy-induced nausea. Journal of Clinical Oncology, 30, 9061.
Chicago
Jeffrey K. Giguere, Ulla Jo Ule, Joanna K. Metzner-Sadurski, Phuong Khanh Morrow, Michael J. Fisch, Steven M. Grunberg, Adedayo A. Onitilo, Steven J. Saccaro, and Mark F. Munsell. 2012. “Randomized Double-Blind Evaluation of Dronabinol for the Prevention of Chemotherapy-Induced Nausea.” Journal of Clinical Oncology 30 (May): 9061. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........a055976fa2ac16a41d6a850c4272435d&authtype=sso&custid=ns315887.